Oncology Brothers: Practice-Changing Cancer Discussions

Latest episodes

Showing 20 · updated from the feed

Rapid Fire Rounds - Thrombocytopenia Workup & Management with Dr. Ronak Mistry

Welcome to the Oncology Brothers podcast! In this episode, we were joined by Dr. Ronak Mistry, a hematologist from Penn Medicine, for a rapid-fire round addressing common

Oct 12
27 min

Challenging Cases in Small Cell Lung Cancer (SCLC) - Drs. Estela Rodriguez & Misty Shields

In this episode of the Oncology Brothers podcast, we dived into two challenging cases of small cell lung cancer (SCLC) to explore the latest supportive care options, the

Oct 8
18 min

WCLC 2026 Highlights: MAVERICK, ADAURA, HARMONi, PAPILLON, DESTINY-Lung04 with Dr. Christine Lovly

Welcome to the Oncology Brothers podcast! In this episode, we were joined by Dr. Christine Lovly, a thoracic medical oncologist from City of Hope, to discuss key studies

Oct 5
19 min

Managing Toxicities of HER2+ Therapies in Upper GI Cancer - Trastuzumab, T-DXd, Zanidatamab

Welcome to the Oncology Brothers podcast! In this episode, we dived into the latest advancements in HER2-targeted therapies for upper gastrointestinal malignancies, with

Sep 30
21 min

Upper GI Treatment Algorithm (Esophageal, Gastric, GEJ) - Dr. Sam Klempner

Welcome to the Oncology Brothers podcast! In this episode, we were joined by Dr. Samuel Klempner, a GI medical oncologist from the Massachusetts General Hospital, to disc

Sep 28
26 min

Follicular & Mantle Cell Lymphoma Treatment Algorithm: Dr. Jonathan Friedberg

In this episode of the Oncology Brothers podcast, we welcomed Dr. Jonathan Friedberg, a leading lymphoma expert, to discuss modern treatment approaches for follicular lym

Sep 24
22 min

Diffuse Large B-cell Lymphoma (DLBCL) Treatment Algorithm: Dr. Mazyar Shadman

In this episode of the Oncology Brothers podcast we had a chance to discuss the current treatment landscape for diffuse large B-cell lymphoma (DLBCL) with Dr. Mazyar Shad

Sep 22
21 min

Revolution Medicines CEO Dr. Mark Goldsmith: Daraxonrasib dream to reality

Welcome to the Oncology Brothers podcast! In this episode, we dove deep into the groundbreaking advancements in pancreatic cancer treatment, focusing on the recent approv

Sep 21
26 min

Camizestrant + CDK 46i FDA Approval in Hormone Receptor Positive Breast Cancer SERENA-6

Welcome to another episode of the Oncology Brothers! In this episode, we dived into the recent FDA approval of camizestrant for the treatment of hormone receptor–positive

Sep 16
20 min

SURPASS-ET: FDA Approval of Ropeginterferon alfa-2b in Essential Thrombocythemia (ET)

Welcome to the Oncology Brothers podcast! In this episode, we talked about the most recent developments in the world of myeloproliferative neoplasms (MPNs), including the

Sep 14
22 min

Myelofibrosis Treatment Algorithm Discussion: Dr. Nico Gagelmann

Welcome to the Oncology Brothers podcast! In this episode, we had the opportunity to dive deep into the treatment algorithm for myelofibrosis with Dr. Nico Gagelmann of D

Sep 7
24 min

Managing Toxicities of Therapies in Polycythemia Vera (PV) / Essential Thrombocythemia (ET)

Welcome back to the Oncology Brothers podcast! In this episode, we were joined by the MPN specialists Drs. Brandi Reeves and Naveen Pemmaraju, to discuss the treatment op

Sep 4
26 min

VERIFY: FDA Approval of Rusfertide in Polycythemia Vera (PV) - Dr. Andrew Kuykendall

Welcome to the Oncology Brothers podcast! In this episode, we dived into the recent approval of rusfertide for polycythemia vera, based on the findings from the VERIFY st

Sep 2
19 min

Polycythemia vera (PV) and Essential thrombocythemia (ET) Treatment Algorithm: Dr. Aaron Gerds

Welcome to the Oncology Brothers podcast! In this episode, we are joined by Dr. Aaron Gerds, a hematologist from the Cleveland Clinic, to discuss the current treatment al

Aug 31
28 min

Multiple Myeloma Management - Partners in Practice with Dr. Ajai Chari Team from UCSF

Welcome to the Oncology Brothers podcast! In this episode of our Partners in Practice series, we dived into the world of multiple myeloma treatment. We had the opportunit

Aug 27
21 min

HERIZON-GEA-01: FDA Approval of Zanidatamab + Tislelizumab for HER2+ Esophageai/GEJ/Gastric Adeno

We had a chance to dive into one of the most significant advancements in the treatment of HER2-positive gastroesophageal junction (GEJ) and gastric adenocarcinoma. In thi

Aug 25
16 min

Rapid Fire Rounds - Multiple Myeloma Management with Dr. Joseph Mikhael

Welcome to the Oncology Brothers podcast and our new series, Rapid Fire Rounds! In this episode, we were joined by Dr. Joseph Mikhael, a myeloma specialist from the City

Aug 24
25 min

EXCALIBER-RRMM - Iberdomide/Dara/Dex FDA Approval for R/R Multiple Myeloma: Dr. Sagar Lonial

Welcome to the Oncology Brothers podcast! In this episode, we were joined by Dr. Sagar Lonial, a myeloma specialist from the Emory University, to discuss the recent FDA a

Aug 20
20 min

Managing Toxicities of Androgen Receptor Pathway Inhibitor (ARPI) in Prostate Cancer

Welcome to the Oncology Brothers podcast! In this episode, we discussed the world of androgen receptor pathway inhibitors (ARPIs) in prostate cancer as part of our Tox Ch

Aug 17
24 min

Challenging Cases in Myelodysplastic Syndrome (MDS) - Dr. Amer Zeidan

Join us with as we dive into two challenging cases of myelodysplastic syndromes (MDS) in this episode featuring Dr. Amer Zeidan, from the Yale School of Medicine. The dis

Aug 13
25 min

Chart trend

Position in the Medicine chart (US), last 90 days.

#1#100#199JulAugSepOct

#71

all-time peak

days in the top 100 since Nov 2024

Chart positions

Where Oncology Brothers: Practice-Changing Cancer Discussions ranks today in each Apple Podcasts chart (US, Oct 19, 2026).

#89 ▲ 4 Medicine US

What listeners say

A curated, balanced selection of Apple Podcasts reviews.

The Oncology brothers do an excellent job of bridging the gap between academia and community oncology. They provide timely oncology updates and discuss the clinical impact, diving into practice changing discussion with guest experts. Hands down my go to resource for oncology updates 🙌

Hemoncdoc_ · Sep 2026

The Oncology Brothers have become a go-to in my week. They take the constant firehose of oncology data—new FDA approvals, shifting algorithms, and “practice-changing” abstracts—and turn it into something practical I can actually use in clinic the next day. The conversations feel like sitting down with smart colleagues who care about evidence, clarity, and real-world decision making, not just reciting trial slides. It’s exactly the kind of thoughtful, high-yield education our field needs more of.

DD1384 · Jan 2026

I regularly listen to this podcast and find it an excellent reference for oncology practice. The speakers consistently provide valuable insights that are both practical and informative. It's a great resource for staying updated and enhancing clinical knowledge.

RHJ, MD · Jul 2025

The Oncology Brothers consistently deliver relevant, easy-to-digest insights on complex data and evolving treatment landscapes. Their ability to break down key updates—especially for those who can't attend every conference—is incredibly valuable. A must-listen for anyone in oncology looking to stay current and connected to the community.

OncoScriber · Jul 2025

We strive to present a balanced view by showing a diverse range of reviews from Apple Podcasts.